Lipid and polymeric carrier-mediated nucleic acid delivery

Area of Science:

• Biotechnology and Pharmaceutical Sciences
• Gene Therapy and Drug Delivery

Background:

• Nucleic acids (plasmid DNA, antisense oligonucleotides, RNA interference molecules) show therapeutic potential for genetic and acquired diseases.
• Successful nucleic acid therapy design necessitates evaluating nucleic acid pharmacology, subject physiology, and carrier physicochemical properties.

Purpose of the Study:

• To provide an overview of biological barriers encountered in nucleic acid delivery.
• To outline strategies for overcoming these barriers through the design of effective synthetic carriers.
• To review commonly used lipids, polymers, and delivery systems for nucleic acid therapeutics.

Main Methods:

• Review of existing literature on lipids, polymers, and their associated delivery systems.
• Analysis of characteristics, applications, advantages, and limitations of various carrier types.
• Examination of biological barriers and design principles for synthetic nucleic acid carriers.

Main Results:

• Identification of key biological barriers impacting nucleic acid delivery efficacy.
• Discussion of strategies to design synthetic carriers that overcome these barriers.
• Overview of the properties, uses, and drawbacks of prevalent lipid and polymeric delivery systems.

Conclusions:

• Understanding biological barriers is crucial for advancing nucleic acid therapy.
• Knowledge of the structure-activity relationship in lipid and polymeric carriers is essential for effective therapeutic design.
• Optimized synthetic carriers are key to unlocking the full potential of nucleic acid therapeutics.